(Stock image generated with AI.)

Canadian stocks ended Tuesday in negative territory as elevated oil prices and soaring bond yields kept market sentiment subdued ahead of the Federal Reserve’s interest rate decision. A rebound in some precious metals, like silver, provided slight support and limited overall losses. Prime Minister Mark Carney unveiled immediate tax write-offs for most new capital investments to attract foreign capital. Statistics Canada also reported wholesale sales rose 0.3% in July, compared to a 2.8% bump in June.

Meanwhile, US markets also declined as investors focused on the Federal Reserve’s upcoming policy meeting, a decision that could influence economic and market conditions. Rising Treasury yields, which reached their highest levels in years, further weighed on equities.

TSX35,582.07-120.46TSX
TSXV900.98-18.89TSXV
CSE177.29-4.53CSE
DJIA52,093.11-328.09DJIA
NASDAQ25,981.57-204.84NASDAQ
S&P 5007,585.73-34.25S&P 500

The Canadian dollar traded for 71.87 cents US compared to 71.93 cents US on Monday.

US crude futures traded US$5.01 higher at US$106.40 a barrel, and the Brent contract rose US$3.56 to US$109.20 a barrel.

The price of gold was down US$14.87 to US$4,296.67.

In world markets, the Nikkei was down 8.89 points to ¥63,484.10, the Hang Seng was down 250.36 points to HK$24,667.24, the FTSE was down 39.44 points to ₤10,658.13, and the DAX was down 38.53 points to €25,402.28.


More From The Market Online
AI risk warnings from Altman, Amodei and Musk pressured tech stocks, while oil surged past $108 on new Hormuz tensions.

Market Open: AI Fears Deepen as Markets Drift Ahead of Fed Decision | Sep 15th #2

AI risk warnings from Altman, Amodei and Musk pressured tech stocks, while oil surged past $108 on new Hormuz tensions.

Brookfield and CPP Investments form $50B Canadian equity fund

Brookfield (TSX:BAM) and CPP Investments launch the Maple Fund, an up to C$50B vehicle to invest in large-scale projects in Canada.

Siemens & Salesforce deepen AI partnership

Siemens (OTC Pink:SIEGY) and Salesforce (NYSE:CRM) expanded their AI partnership by integrating Agentforce with Teamcentre.

Cancer fighter Theralase aims to turn lab wins into human trials

Theralase (TSXV:TLT) begins Good Laboratory Practice toxicology analysis of Rutherrin, its drug candidate to target and destroy cancer cells.